Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-derived peptide ligand: potential tool for drug delivery
- PMID: 20153412
- DOI: 10.1016/j.ijpharm.2010.02.003
Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-derived peptide ligand: potential tool for drug delivery
Abstract
Cell specific targeting is an emerging field in nanomedicine. Homing of the multifunctional nanoparticles (MFNPs) is achieved by the conjugation of targeting moieties on the nanoparticle surface. The inner ear is an attractive target for new drug delivery strategies as it is hard to access and hearing loss is a significant worldwide problem. In this work we investigated the utility of a Nerve Growth Factor-derived peptide (hNgf_EE) functionalized nanoparticles (NPs) to target cells of the inner ear. These functionalized NPs were introduced to organotypic explant cultures of the mouse inner ear and to PC-12 rat pheochromocytoma cells. The NPs did not show any signs of toxicity. Specific targeting and higher binding affinity to spiral ganglion neurons, Schwann cells and nerve fibers of the explant cultures were achieved through ligand mediated multivalent binding to tyrosine kinase receptors and to p75 neurotrophin receptors. Unspecific uptake of NPs was investigated using NPs conjugated with scrambled hNgf_EE peptide. Our results indicate a selective cochlear cell targeting by MFNPs, which may be a potential tool for cell specific drug and gene delivery to the inner ear.
Copyright 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin.Biomaterials. 2011 Jan;32(1):152-61. doi: 10.1016/j.biomaterials.2010.09.014. Epub 2010 Oct 14. Biomaterials. 2011. PMID: 20889205
-
Transsynaptic delivery of nanoparticles to the central auditory nervous system.Acta Otolaryngol. 2007 May;127(5):486-90. doi: 10.1080/00016480600895102. Acta Otolaryngol. 2007. PMID: 17453474
-
LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors.Int J Pharm. 2010 Jan 29;385(1-2):150-6. doi: 10.1016/j.ijpharm.2009.10.014. Epub 2009 Oct 13. Int J Pharm. 2010. PMID: 19825404
-
Anticancer drug delivery with nanoparticles.In Vivo. 2006 Nov-Dec;20(6A):697-701. In Vivo. 2006. PMID: 17203748 Review.
-
Nanomedicine strategies for drug delivery to the ear.Nanomedicine (Lond). 2013 Jul;8(7):1155-72. doi: 10.2217/nnm.13.104. Nanomedicine (Lond). 2013. PMID: 23837855 Review.
Cited by
-
Nuclear entry of hyperbranched polylysine nanoparticles into cochlear cells.Int J Nanomedicine. 2011;6:535-46. doi: 10.2147/IJN.S16973. Epub 2011 Mar 14. Int J Nanomedicine. 2011. PMID: 21468356 Free PMC article.
-
Evaluation of Intracochlear Pressure and Fluid Distribution in 3D-Printed Artificial Cochlear Models and Human Petrous Bones.Brain Sci. 2025 Jul 20;15(7):771. doi: 10.3390/brainsci15070771. Brain Sci. 2025. PMID: 40722361 Free PMC article.
-
Developments in Bio-Inspired Nanomaterials for Therapeutic Delivery to Treat Hearing Loss.Front Cell Neurosci. 2019 Nov 6;13:493. doi: 10.3389/fncel.2019.00493. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31780898 Free PMC article. Review.
-
Growth factor choice is critical for successful functionalization of nanoparticles.Front Neurosci. 2015 Sep 2;9:305. doi: 10.3389/fnins.2015.00305. eCollection 2015. Front Neurosci. 2015. PMID: 26388717 Free PMC article.
-
Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss.Adv Drug Deliv Rev. 2017 Jan 1;108:2-12. doi: 10.1016/j.addr.2016.01.004. Epub 2016 Jan 12. Adv Drug Deliv Rev. 2017. PMID: 26796230 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials